Company Overview and News

 
KLCI to trend sideways, support seen at 1,625

2016-06-05 theedgemarkets
KUALA LUMPUR (June 6): The FBM KLCI is likely to trend sideways today with support pegged at 1,625 points, as the weaker close at global markets last Friday may weigh down local sentiment.

 
S P Setia, E&O, Mega First, Jadi Imaging, Scomi Engineering, CIMB, Rex Industry, Hwa Tai, Tune Protect, Hap Seng Consolidated, Alam Maritim, CAB Cakaran and Farm's Best

2016-06-05 theedgemarkets
KUALA LUMPUR (June 3): Based on corporate announcements and news flow today, companies that may be in focus on Monday (June 6) could include the following: S P Setia, E&O, Mega First, Jadi Imaging, Scomi Engineering, CIMB, Rex Industry, Hwa Tai, Tune Protect, Hap Seng Consolidated, Alam Maritim, CAB Cakaran and Farm's Best.

 
KLCI to trend sideways, support seen at 1,625

2016-06-05 www2.theedgemarkets
KUALA LUMPUR (June 6): The FBM KLCI is likely to trend sideways today with support pegged at 1,625 points, as the weaker close at global markets last Friday may weigh down local sentiment.

 
S P Setia, E&O, Mega First, Jadi Imaging, Scomi Engineering, CIMB, Rex Industry, Hwa Tai, Tune Protect, Hap Seng Consolidated, Alam Maritim, CAB Cakaran and Farm's Best

2016-06-03 www2.theedgemarkets
KUALA LUMPUR (June 3): Based on corporate announcements and news flow today, companies that may be in focus on Monday (June 6) could include the following: S P Setia, E&O, Mega First, Jadi Imaging, Scomi Engineering, CIMB, Rex Industry, Hwa Tai, Tune Protect, Hap Seng Consolidated, Alam Maritim, CAB Cakaran and Farm's Best.

 
KLCI falls 0.62%, key blue chips weigh

2016-04-26 theedgemarkets
KUALA LUMPUR (April 26): The FBM KLCI fell 0.62% at mid-morning in line with the weaker regional markets, extending its consolidation.

 
KLCI pares gains as regional markets slip

2016-02-25 themalaysianoutsider
The FBM KLCI pared some of its gains at the midday break as regional markets slipped while decliners outpaced advancing issuers. At 12.30pm, the FBM KLCI…

 
KLCI pares gains as regional markets slip

2016-02-25 themalaysianinsider
The FBM KLCI pared some of its gains at the midday break as regional markets slipped while decliners outpaced advancing issuers. At 12.30pm, the FBM KLCI…

 
KLCI pares gains as regional markets slip

2016-02-25 theedgemarkets
KUALA LUMPUR (Feb 25): The FBM KLCI pared some of its gains at the midday break as regional markets slipped while decliners outpaced advancing issuers. At 12.30pm, the FBM KLCI was up 1.07 points at 1,665.24. The index had earlier risen to its intra-morning high of 1,672.56. Losers led gainers by 387 to 248, while 346 counters traded unchanged. Volume was 913.47 million shares valued at RM691.32 million.

 
KLCI rises higher despite shaky regional markets.

2016-02-25 theedgemarkets
KUALA LUMPUR (Feb 25): The FBM KLCI rose higher at mid-morning, lifted by key blue chip stocks, despite a shaky start at most regional markets. At 10am, the FBM KLCI rose 7.04 points to 1,671.21. The top gainers included Dutch Lady Milk Industries Bhd, British American Tobacco (M) Bhd, Fraser & Neave Holdings Bhd, Sime Darby Bhd, JMR Conglomeration Bhd, UMW Holdings Bhd,Hong Leong Industries Bhd and Axiata Group Bhd.

 
Jadi Imaging shares soars 20% on active trading

2016-02-19 themalaysianinsider
Actively traded Jadi Imaging Holdings Bhd's shares rose 20%, or 2 sen, to 12 sen after the toner manufacturer swung back to profitability in the 12-month…

 
KLCI retreats in line with regional markets

2016-02-19 themalaysianinsider
The FBM KLCI retreated at the midday break today in line with regional markets that slipped after the recent rally. At 12.30pm, the FBM KLCI fell 2.55…

 
KLCI retreats in line with regional markets

2016-02-19 theedgemarkets
KUALA LUMPUR (Feb 19): The FBM KLCI retreated at the midday break today in line with regional markets that slipped after the recent rally. At 12.30pm, the FBM KLCI fell 2.55 points to 1,677.47. Among the indices, construction, consumer, finance and plantation were in the red. The top losers included Nestle (M) Bhd, Genting Bhd, Lafarge Malaysia Bhd, TIME dotCom Bhd, C.I. Holdings Bhd, Globetronics Technology Bhd, Genting Plantations Bhd, JMR Conglomeration Bhd, PLB Engineering Bhd and LPI Capital Bhd.

 
KLCI reverses loss, market to remain volatile

2016-02-19 themalaysianinsider
The FBM KLCI reversed its losses at mid-morning but the market is expected to remain volatile in line with the global uncertainties. At 10am, the FBM KLCI…

 
FBM KLCI opens lower

2016-02-19 themalaymailonline
KUALA LUMPUR, Feb 19 — The FBM KLCI opened lower today on profit-taking activities and in line the weaker overnight performance on Wall Street.  At 9.10am, the benchmark index fell 3.01 points to 1,677.01 from yesterday’s close of

 
KLCI reverses loss, market to remain volatile

2016-02-19 theedgemarkets
KUALA LUMPUR (Feb 19): The FBM KLCI reversed its losses at mid-morning but the market is expeced to remain volative in line with the global uncertainties. At 10am, the FBM KLCI rose 1.55 points to 1,681.57. The index had earlier slipped to a low of 1,673.84. The top gainers included Kuala Lumpur Kepong Bhd, Panasoni Malaysia Manufacturing Bhd, Sin Heng Chan (Malaya) Bhd, Ta Ann Holdings Bdh, PPB Group Bhd, Texchem Resources Bhd, MISC Bhd, Aeon Credit Services (M) Bhd, KLCC Property Holdings Bhd and Tenaga Nasional Bhd.

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...